These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 16557781)
41. Protection against bovine tuberculosis induced by oral vaccination of cattle with Mycobacterium bovis BCG is not enhanced by co-administration of mycobacterial protein vaccines. Wedlock DN; Aldwell FE; Vordermeier HM; Hewinson RG; Buddle BM Vet Immunol Immunopathol; 2011 Dec; 144(3-4):220-7. PubMed ID: 22005585 [TBL] [Abstract][Full Text] [Related]
43. Immunogenicity and protective efficacy of a fusion protein vaccine consisting of antigen Ag85B and HspX against Mycobacterium tuberculosis infection in mice. Li Q; Yu H; Zhang Y; Wang B; Jiang W; Da Z; Xian Q; Wang Y; Liu X; Zhu B Scand J Immunol; 2011 Jun; 73(6):568-76. PubMed ID: 21323695 [TBL] [Abstract][Full Text] [Related]
44. Host-parasite relationships in experimental airborne tuberculosis. V. Lack of hematogenous dissemination of Mycobacterium tuberculosis to the lungs in animals vaccinated with Bacille Calmette-Guérin. Fok JS; Ho RS; Arora PK; Harding GE; Smith DW J Infect Dis; 1976 Feb; 133(2):137-44. PubMed ID: 812927 [TBL] [Abstract][Full Text] [Related]
45. [Effect of atypical mycobacterial infection on the cell-mediated immunity induced by Mycobacterium bovis BCG in mice. II. Suppression of protective immunity]. Nakamura RM Kekkaku; 1993 May; 68(5):361-5. PubMed ID: 8331880 [TBL] [Abstract][Full Text] [Related]
46. Infection with the helminth Nippostrongylus brasiliensis does not interfere with efficient elimination of Mycobacterium bovis BCG from the lungs of mice. Erb KJ; Trujillo C; Fugate M; Moll H Clin Diagn Lab Immunol; 2002 May; 9(3):727-30. PubMed ID: 11986288 [TBL] [Abstract][Full Text] [Related]
47. DNA vaccine encoding ESAT-6 enhances the protective efficacy of BCG against Mycobacterium tuberculosis infection in mice. Fan X; Gao Q; Fu R Scand J Immunol; 2007 Nov; 66(5):523-8. PubMed ID: 17916110 [TBL] [Abstract][Full Text] [Related]
48. Mucosal immunization with recombinant heparin-binding haemagglutinin adhesin suppresses extrapulmonary dissemination of Mycobacterium bovis bacillus Calmette-Guérin (BCG) in infected mice. Kohama H; Umemura M; Okamoto Y; Yahagi A; Goga H; Harakuni T; Matsuzaki G; Arakawa T Vaccine; 2008 Feb; 26(7):924-32. PubMed ID: 18192091 [TBL] [Abstract][Full Text] [Related]
49. A new tool for tuberculosis vaccine screening: Ex vivo Mycobacterial Growth Inhibition Assay indicates BCG-mediated protection in a murine model of tuberculosis. Zelmer A; Tanner R; Stylianou E; Damelang T; Morris S; Izzo A; Williams A; Sharpe S; Pepponi I; Walker B; Hokey DA; McShane H; Brennan M; Fletcher H BMC Infect Dis; 2016 Aug; 16():412. PubMed ID: 27519524 [TBL] [Abstract][Full Text] [Related]
50. Resistance of high and low antibody responder lines of mice to the growth of avirulent (BCG) and virulent (H37Rv) strains of mycobacteria. Gheorghiu M; Mouton D; Lecoeur H; Lagranderie M; Mevel JC; Biozzi G Clin Exp Immunol; 1985 Jan; 59(1):177-84. PubMed ID: 3882283 [TBL] [Abstract][Full Text] [Related]
51. Exposure to Mycobacterium avium can modulate established immunity against Mycobacterium tuberculosis infection generated by Mycobacterium bovis BCG vaccination. Flaherty DK; Vesosky B; Beamer GL; Stromberg P; Turner J J Leukoc Biol; 2006 Dec; 80(6):1262-71. PubMed ID: 16968819 [TBL] [Abstract][Full Text] [Related]
52. Dominant-negative tumor necrosis factor protects from Mycobacterium bovis Bacillus Calmette Guérin (BCG) and endotoxin-induced liver injury without compromising host immunity to BCG and Mycobacterium tuberculosis. Olleros ML; Vesin D; Lambou AF; Janssens JP; Ryffel B; Rose S; Frémond C; Quesniaux VF; Szymkowski DE; Garcia I J Infect Dis; 2009 Apr; 199(7):1053-63. PubMed ID: 19222369 [TBL] [Abstract][Full Text] [Related]
53. A new vaccine against tuberculosis shows greater protection in a mouse model with progressive pulmonary tuberculosis. Castañon-Arreola M; López-Vidal Y; Espitia-Pinzón C; Hernández-Pando R Tuberculosis (Edinb); 2005; 85(1-2):115-26. PubMed ID: 15687035 [TBL] [Abstract][Full Text] [Related]
56. Efficacy of Mycobacterium bovis BCG vaccination in mice undergoing prior pulmonary infection with atypical mycobacteria. Orme IM; Collins FM Infect Immun; 1984 Apr; 44(1):28-32. PubMed ID: 6423543 [TBL] [Abstract][Full Text] [Related]
57. A live attenuated BCG vaccine overexpressing multistage antigens Ag85B and HspX provides superior protection against Mycobacterium tuberculosis infection. Yuan X; Teng X; Jing Y; Ma J; Tian M; Yu Q; Zhou L; Wang R; Wang W; Li L; Fan X Appl Microbiol Biotechnol; 2015 Dec; 99(24):10587-95. PubMed ID: 26363555 [TBL] [Abstract][Full Text] [Related]
58. Protection by live Mycobacterium habana vaccine against Mycobacterium tuberculosis H37Rv challenge in mice. Prem Raj P; Srivastava S; Jain SK; Srivastava BS; Srivastava R Indian J Med Res; 2003 Apr; 117():139-45. PubMed ID: 14604301 [TBL] [Abstract][Full Text] [Related]
59. Monocyte response receptors in BCG driven delayed type hypersensitivity to tuberculin. Strapagiel D; Kasztalska K; Druszczyńska M; Kowalewicz-Kulbat M; Vrba A; Matusiak A; Chmiela M; Rudnicka W Folia Histochem Cytobiol; 2008; 46(3):353-9. PubMed ID: 19056540 [TBL] [Abstract][Full Text] [Related]
60. Lee H; Kim J; Kang YA; Kim DR; Sim B; Zelmer A; Fletcher HA; Dockrell HM; Smith SG; Cho SN Front Immunol; 2019; 10():896. PubMed ID: 31105706 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]